Next |
home / stock / adxn / adxn message board
Subject | By | Source | When |
---|---|---|---|
Watch for this to have its days, low | harry crumb | investorshub | 05/11/2023 1:00:53 AM |
The float is already traded... big boom ahead imo | Klinsmann | investorshub | 05/10/2023 10:46:10 AM |
Addex Announces ADX71149 Phase 2 Epilepsy Clinical Studys | subslover | investorshub | 05/10/2023 9:59:36 AM |
Price trading up | glenn1919 | investorshub | 05/09/2023 3:35:34 AM |
$ADXN MomentumIts gaining | willlbone | investorshub | 05/07/2023 8:43:30 AM |
Anyone hear anything lately? Want to see this one go | willlbone | investorshub | 05/04/2023 6:42:39 AM |
Price now up | dealerschool2006 | investorshub | 05/04/2023 4:46:36 AM |
$ADXN are we finally gonna see some action | tickersym | investorshub | 05/02/2023 2:16:52 PM |
The now | SubPennyBoater | investorshub | 04/30/2023 10:11:28 PM |
Price gaining up | dealerschool2006 | investorshub | 04/28/2023 1:31:11 PM |
$ADXN Price gaining | subslover | investorshub | 04/25/2023 3:54:36 PM |
bears and bulls | SubPennyBoater | investorshub | 04/22/2023 6:24:00 AM |
$ADXN Price now last trade up | subslover | investorshub | 04/18/2023 3:50:57 AM |
$ADXN short data if anyone is interested | SubPennyBoater | investorshub | 04/16/2023 7:37:09 AM |
got some short data | willlbone | investorshub | 04/13/2023 7:27:33 PM |
good read | subslover | investorshub | 04/12/2023 6:15:53 AM |
Price now | subslover | investorshub | 04/10/2023 3:34:20 PM |
Buy some 90s | willlbone | investorshub | 03/13/2023 7:39:23 PM |
ADXN.................................https://stockcharts.com/h-sc/ui?s=ADXN&p=W& | glenn1919 | investorshub | 02/25/2023 1:44:33 PM |
Sold most at 1.37, then the rest 1.33 today. | SubPennyBoater | investorshub | 08/05/2022 8:48:42 PM |
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
2.73% G/L:
$7.30 Last:
21,281 Volume:
$7.49 Open:
$7.30 Close:
Addex Therapeutics Ltd Website:
Geneva, Switzerland, January 8, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that Dr Robert Lütjens, Head of Disco...
Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND enabling studies Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, November 22, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage ...
CISO Global, Inc (CISO) is expected to report for Q3 2024 Applied Energetics Inc (AERG) is expected to report for Q3 2024 Sphere 3D Corp. (ANY) is expected to report $-0.19 for Q3 2024 Atossa Therapeutics Inc. (ATOS) is expected to report $-0.05 for Q3 2024 Community Bancorp Inc V...